Acute Promyelocytic Leukemia Apl clinical trials

Explore recruiting acute promyelocytic leukemia apl clinical trials.

Recruiting acute promyelocytic leukemia apl studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Acute Promyelocytic Leukemia Apl trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

ICC APL STUDY 02 Treatment study for children and adolescents with Acute Promyelocytic Leukemia

Netherlands, Italy, Sweden, Czechia, France

Therapeutic exploratory (Phase II) EU CTIS Study details

Acute Promyelocytic Leukemia Apl trials by city

Acute Promyelocytic Leukemia Apl clinical trials

Recruiting acute promyelocytic leukemia apl studies right now

PET/MRI, 18F-FDG PET/CT and Whole Body MRI in Finding Extramedullary Myeloid Leukemia in Patients With Newly Diagnosed Acute Myeloid Leukemia

Early Use of Realgar-Indigo Naturalis Formula (RIF) Combined With All-trans Retinoic Acid (ATRA) for Treating Acute Promyelocytic Leukemia (APL).

Frontline Oral Arsenic Trioxide for APL

Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia

Tretinoin and Arsenic Trioxide With or Without Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia

Oral Arsenic With ATRA for Newly Diagnosed Patients With Acute Promyelocytic Leukemia

Treatment of Chidamide and Venetoclax for Retinoic Acid and Arsenic Resistant Acute Promyelocytic Leukemia

Treatment Study for Children and Adolescents With Acute Promyelocytic Leukemia

Also recruiting in Europe

ICC APL STUDY 02 Treatment study for children and adolescents with Acute Promyelocytic Leukemia

Acute Promyelocytic Leukemia Apl trials by city

Other conditions